These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32394513)

  • 1. Chloroquine and hydroxychloroquine for COVID-19: A word of caution.
    Annangi S
    Respirology; 2020 Jul; 25(7):683-684. PubMed ID: 32394513
    [No Abstract]   [Full Text] [Related]  

  • 2. Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
    Guastalegname M; Vallone A
    Clin Infect Dis; 2020 Jul; 71(15):888-889. PubMed ID: 32211771
    [No Abstract]   [Full Text] [Related]  

  • 3. Update Alert 2: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
    Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM
    Ann Intern Med; 2020 Oct; 173(7):W128-W129. PubMed ID: 32853033
    [No Abstract]   [Full Text] [Related]  

  • 4. Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.
    Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Humphrey LL
    Ann Intern Med; 2020 Sep; 173(5):W88-W89. PubMed ID: 32730105
    [No Abstract]   [Full Text] [Related]  

  • 5. Chloroquine and COVID-19: A western medical and scientific drift?
    Million M; Roussel Y; Raoult D
    Eur J Intern Med; 2020 Aug; 78():4-5. PubMed ID: 32600860
    [No Abstract]   [Full Text] [Related]  

  • 6. Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019.
    Fihn SD; Perencevich E; Bradley SM
    JAMA Netw Open; 2020 Apr; 3(4):e209035. PubMed ID: 32330276
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.
    Guzman-Prado Y
    Am J Cardiol; 2020 Sep; 130():162-163. PubMed ID: 32624192
    [No Abstract]   [Full Text] [Related]  

  • 8. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
    Malviya A
    Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
    [No Abstract]   [Full Text] [Related]  

  • 9. Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
    Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM
    Ann Intern Med; 2020 Aug; 173(4):W78-W79. PubMed ID: 32667853
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 and Depression.
    Shader RI
    Clin Ther; 2020 Jun; 42(6):962-963. PubMed ID: 32362345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.
    Colson P; Rolain JM; Lagier JC; Brouqui P; Raoult D
    Int J Antimicrob Agents; 2020 Apr; 55(4):105932. PubMed ID: 32145363
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).
    Ruamviboonsuk P; Lai TYY; Chang A; Lai CC; Mieler WF; Lam DSC
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):375-376. PubMed ID: 32740072
    [No Abstract]   [Full Text] [Related]  

  • 13. Chloroquine, Hydroxychloroquine, Retinal Toxicity, and COVID-19.
    Wiwanitkit V
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):374. PubMed ID: 32740070
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
    Ibáñez S; Martínez O; Valenzuela F; Silva F; Valenzuela O
    Clin Rheumatol; 2020 Aug; 39(8):2461-2465. PubMed ID: 32495226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
    Marmor MF
    Am J Ophthalmol; 2020 Aug; 216():A1-A2. PubMed ID: 32439074
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Avidan MS; Dehbi HM; Delany-Moretlwe S
    N Engl J Med; 2020 Sep; 383(11):1087-1088. PubMed ID: 32668106
    [No Abstract]   [Full Text] [Related]  

  • 17. Benefit v. risk when using chloroquine in patients with severe COVID-19 disease.
    Decloedt EH; Reuter H; Allwood B; Parker A; Koegelenberg CFN; Blockman M; Taljaard J
    S Afr Med J; 2020 Apr; 110(5):12903. PubMed ID: 32657706
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.
    Okafor EC; Pastick KA; Rajasingham R
    N Engl J Med; 2020 Sep; 383(11):1089. PubMed ID: 32668109
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Tekwani BL
    N Engl J Med; 2020 Sep; 383(11):1088-1089. PubMed ID: 32668108
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Khan MS; Butler J
    N Engl J Med; 2020 Sep; 383(11):1088. PubMed ID: 32668107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.